Skip to search formSkip to main contentSkip to account menu

Apheresis (procedure)

Known as: Phereses, Aphereses, Blood Component Removal 
A procedure in which blood is collected, part of the blood such as platelets or white blood cells is taken out, and the rest of the blood is returned… 
National Institutes of Health

Related topics

Related topics

15 relations
Apheresis available:Num:Pt:^BPU:QnCell SeparationHematopoietic Stem Cell MobilizationLDL apheresis procedure:ID:Pt:^Patient:Nom

Narrower (5)

Blood bagCOLUMNS, IMMUNOADSORPTION IN EXTRACORPOREAL SYSTEMSLeukapheresisPlasma Exchange

Broader (1)

physicochemically based treatment methods

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2013
Review
2013
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice—Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Sixth Special Issue
The American Society for Apheresis (ASFA) JCA Special Issue Writing Committee is charged with reviewing, updating and… 
Highly Cited
2011
Highly Cited
2011
First-line therapy with coagulation factor concentrates combined with point-of-care coagulation testing is associated with decreased allogeneic blood transfusion in cardiovascular surgery: a…
INTRODUCTION Blood transfusion is associated with increased morbidity and mortality. We developed and implemented an algorithm… 
Highly Cited
2011
Highly Cited
2011
Pilot Study of Extracorporeal Removal of Soluble Fms-Like Tyrosine Kinase 1 in Preeclampsia
Background— Targeted therapies to stabilize the clinical manifestations and prolong pregnancy in preeclampsia do not exist… 
Highly Cited
2006
Highly Cited
2006
Soluble CD40 ligand accumulates in stored blood components, primes neutrophils through CD40, and is a potential cofactor in the development of transfusion-related acute lung injury.
Transfusion-related acute lung injury (TRALI) is a form of posttransfusion acute pulmonary insufficiency that has been linked to… 
Highly Cited
2005
Highly Cited
2005
Factors affecting posttransfusion platelet increments, platelet refractoriness, and platelet transfusion intervals in thrombocytopenic patients.
A variety of patient and product-related factors influenced the outcome of 6379 transfusions given to 533 patients in the Trial… 
Highly Cited
1997
Highly Cited
1997
Randomized study of prophylactic platelet transfusion threshold during induction therapy for adult acute leukemia: 10,000/microL versus 20,000/microL.
PURPOSE We designed and conducted a randomized single-institution trial comparing two common prophylactic platelet transfusion… 
Highly Cited
1995
Highly Cited
1995
Collection and transfusion of blood and blood components in the United States, 1992
BACKGROUND: Studies were conducted to measure the state of the United States' national blood resource in 1992 and changes therein… 
Review
1991
Review
1991
The evolving role of autologous peripheral stem cell transplantation following high-dose therapy for malignancies.
Over the last decade, transplantation of circulating autologous hematopoietic stem cells to facilitate the recovery of bone… 
Highly Cited
1990
Highly Cited
1990
Single high doses of cyclophosphamide enable the collection of high numbers of hemopoietic stem cells from the peripheral blood.
We used single high doses of cyclophosphamide (4 g/m2) to produce rebound increases in peripheral blood (PB) stem cells (PBSC… 
Highly Cited
1988
Highly Cited
1988
Autologous peripheral hematopoietic stem cell transplantation restores hematopoietic function following marrow ablative therapy.
From ten patients with advanced malignant disease involving the bone marrow, autologous hematopoietic stem cells were collected… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)